PROSCA & BLADDR 2022

 

PROSCA & BLADDR 2022
K

Systemic Treatment in High-Risk Localized Prostate Cancer

By PROSCA & BLADDR 2022 FEATURING Karim Fizazi
By PROSCA & BLADDR 2022 FEATURING Karim Fizazi
328 views
December 28, 2022
Comments 0
Login to view comments. Click here to Login
PROSCA
18:23

Multicancer Early Detection

PROSCA & BLADDR 2022

E. Klein

107 views
15:14

The Future of Prostate Cancer Pathology

PROSCA & BLADDR 2022

E. Comperat

128 views
14:25

The Future of External Beam Radiotherapy for Prostate Cancer

PROSCA & BLADDR 2022

A. Bossi

77 views
14:13

A Medical Oncologist’s Perspective on Therapy Development in Prostat…

PROSCA & BLADDR 2022

E. Efstathiou

633 views
13:54

Oligorecurrent Prostate Cancer

PROSCA & BLADDR 2022

J. Murray

162 views
13:58

Optimal Strategies for Prostate Cancer Patients Progressing on AR-Pa…

PROSCA & BLADDR 2022

A. Bahl

115 views
17:24

PARPi in Prostate Cancer: Single Agents and Combinations

PROSCA & BLADDR 2022

E. Castro

137 views
15:09

Optimal Strategies for Prostate Cancer Patients Progressing on AR-Pa…

PROSCA & BLADDR 2022

K. Herrmann

46 views
13:43

Prostate Cancer Treatment Intensification With Chemotherapy: Does Vo…

PROSCA & BLADDR 2022

S. Gillessen

215 views
17:27

Prostate Cancer Treatment Intensification With Radiotherapy: Does Vo…

PROSCA & BLADDR 2022

N. James

138 views
14:51

Prostate Cancer: Managing Cardiovascular and Skeletal Comorbidities

PROSCA & BLADDR 2022

A. Bahl

270 views
17:59

Role of Surgery in Very High-Risk Prostate Cancer

PROSCA & BLADDR 2022

S. Joniau

102 views
17:38

Radiotherapy in Very High-Risk Prostate Cancer

PROSCA & BLADDR 2022

A. Bossi

231 views
14:37

Systemic Treatment in High-Risk Localized Prostate Cancer

PROSCA & BLADDR 2022

K. Fizazi

328 views
14:28

The Added Benefit of New Imaging for (Very) High-Risk Prostate Cance…

PROSCA & BLADDR 2022

A. Padhani

129 views
17:35

Impact of Genomic Classifiers on Postoperative Prostate Cancer Treat…

PROSCA & BLADDR 2022

A. Dal Pra

42 views
08:38

DEBATE: Do We Postpone Salvage RT Until a Positive PSMA-PET/CT? Yes

PROSCA & BLADDR 2022

R. van den Bergh

43 views
08:59

DEBATE: Do We Postpone Salvage RT Until a Positive PSMA-PET/CT? No

PROSCA & BLADDR 2022

J. Murray

59 views
19:11

Follow-Up After Radical Therapy for Prostate Cancer: Not All That Sh…

PROSCA & BLADDR 2022

K. Goffin

121 views
09:37

PSMA-PET/CT-Based RT for Prostate Cancer in Salvage Setting

PROSCA & BLADDR 2022

V. Achard

48 views
09:19

PC-PEP Randomized Trial: The Prostate Cancer - Patient Empowerment P…

PROSCA & BLADDR 2022

G. Ilie

15 views
05:40

MINT Trial: Lymph Node Staging With 18F-PSMA PET/CT in Newly Diagnos…

PROSCA & BLADDR 2022

J. van Basten

32 views
04:41

Adoption of Active Surveillance Protocols for Prostate Cancer Remain…

PROSCA & BLADDR 2022

F. Kapogiannis

12 views
21:32

Genomic Risk Assessment for Active Surveillance in Prostate Cancer

PROSCA & BLADDR 2022

E. Klein

58 views
13:54

Management of Intermediate Risk Prostate Cancer: The Role of Imaging…

PROSCA & BLADDR 2022

A. Padhani

341 views
62:13

Highlights of the Advanced Prostate Cancer Consensus Conference (APC…

PROSCA & BLADDR 2022

A. Omlin, S. Gillessen

33 views
14:47

New Concepts in Prostate Cancer Pathology

PROSCA & BLADDR 2022

E. Comperat

78 views
18:20

Immunotherapy in Prostate Cancer

PROSCA & BLADDR 2022

A. Omlin

41 views
20:52

AR Antagonists for Prostate Cancer: Are They All Equal?

PROSCA & BLADDR 2022

B. Tombal

231 views